Claudia Roth, Ph.D., was appointed President of Vetter Development Service USA in 2010. She is responsible for the operations and administration of Vetter’s early-stage clinical manufacturing facility in Chicago, Illinois, the company’s first U.S. site. Dr. Roth joined Vetter, a leading contract development and manufacturing organization (CDMO), in 2000 at the company’s headquarters in Ravensburg, Germany. Starting in the company’s aseptic production group, she later moved to Vetter’s research and development organization, where she built and led the division’s first process development and implementation function. Dr. Roth studied chemical/process engineering at the Friedrich-Alexander University of Erlangen in Nuremberg, Germany, receiving a Ph.D. in lyophilization (freeze-drying), which she executed at Roche Diagnostics in Mannheim, Germany. A recognized expert in lyophilization, she regularly presents at industry forums on topics related to aseptic manufacturing.